EWTX News

In a turbulent week for the IPO market, 17 IPOs and 20 SPACs went public, and one company postponed, defense contractor Leonardo DRS (DRS). While returns cooled off, with just over half of the week’s IPOs finishing below issue, there were a few bright spots, led by biotechs Design Therapeutics (DSGN) and Ikena Oncology...read more

Edgewise Therapeutics, a Phase 1 biotech developing small molecule therapies for rare muscle disorders, raised $176 million by offering 11 million shares at $16, the high end of the range of $14 to $16. The company offered 1 million more shares than anticipated. Edgewise is focused on the discovery, development, and commercialization of innovative treatments for severe, rare...read more

Edgewise Therapeutics, a Phase 1 biotech developing small molecule therapies for rare muscle disorders, announced terms for its IPO on Monday. The Boulder, CO-based company plans to raise $150 million by offering 10 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Edgewise Therapeutics would command a fully diluted market value of $806...read more

Updated Monday, 3/22. 15 IPOs are currently scheduled to raise $5.7 billion in the week ahead as IPO activity continues to pick up. The diverse group spans six sectors and includes cleaning products, defense technology, low-cost TVs, crafting machines, and more. Cleaning products maker Diversey Holdings (DSEY) plans to raise $900 million at a $5...read more